Capital Alliance between Otsuka Pharmaceutical Factory nba scores Neuroceuticals

Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President nba scores Representative Director: Shinichi Ogasawara; "OPF") has invested in nba scores taken a stake in a medical device venture company Neuroceuticals, Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President nba scores Representative Director: Shinya Miike; "NCI").

OPF nba scores NCI have been working together since 2019 to develop advanced medical devices, nba scores now OPF has invested in NCI to further strengthen these efforts. We intend to advance the development of innovative medical devices that solve the challenges of various clinical needs in clinical practice, nba scores work together to provide better medical care.

[About OPF]
OPF manufactures nba scores sells pharmaceutical products, medical devices, nba scores functional foods, with a focus on clinical nutrition products, nba scores its management vision is "The Best Partner in Clinical Nutrition." With this investment, OPF aims to develop advanced medical devices that can only be achieved by a company that has strengths in the area of clinical nutrition.

[About NCI]
NCI is a medical device development venture focused on creating value mainly through product nba scores application development nba scores the development of critical components in the medical field. NCI also uses its own marketing network to search for needs focusing on equipment that doctors need, equipment that enables more efficient diagnosis nba scores treatment, nba scores equipment that enhances the quality of life of patients, nba scores releases products, including those procured overseas.